Everyday Health on MSN

Is This Weird Bleeding a Sign of Cancer?

Learn when weird or abnormal bleeding might signal cancer and when to call your doctor or primary care professional.
Navi Mumbai, March 5: A 37-year-old woman suffering from a rare genetic bleeding disorder that caused severe menstrual bleeding for years has been successfully treated through a robotic hysterectomy, ...
Frequent running and heavy lifting can increase vein pressure. Know why athletes develop varicose veins, early symptoms to watch for, and when to seek help.
Once confined to science fiction, biologic therapies now harness growth factors and cellular signaling to reduce inflammation, restore function, and support natural healing.
CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Acquires 12-LOX Inhibitor VLX-1005 for the Treatment of HIT In December 2025, Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) announced the ...
Acute myeloid leukemia, often called AML, is one of the most aggressive forms of blood cancer. It develops in the bone marrow, the soft tissue inside bones where blood cells are made. In healthy ...
Acute Lymphocytic Leukemia (ALL) is a serious type of cancer that affects the blood and bone marrow. It moves very quickly, meaning it needs fast and strong treatment. In ALL, the body starts making ...
By the time cancer symptoms appear, the disease has already been developing for years, often leaving subtle clues in routine ...
A La Crosse woman whose life was saved by a stem cell transplant is now working to help others find the same second chance, by encouraging more people to join ...
After that, it's time for us all to work on it," Bennett noted, adding that he "won't speak for the BBC" or to its plans. In terms of the BBC, BBC Studios serves as a commercial production and ...
RuPaul's Drag Race Season 17 Episode 15: "Lip Sync Lalaparuza Smackdown" – All of the eliminated queens return to battle it out in a Lip Sync Lalaparuza Smackdown, with eight lip syncs, and a cash ...
Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...